Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer
Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer
复制标题
表达TRAIL的端粒酶特异性溶瘤腺病毒抑制胃癌腹膜播散
DOI:
10.1038/gt.2017.2
复制
发表时间:
2017-01
期刊:
影响因子:
5.1
通讯作者:
Huang X.
中科院分区:
文献类型:
--
作者:
Zhou W.;Dai S.;Zhu H.;Song Z.;Cai Y.;Lee J. B.;Li Z.;Hu X.;Fang B.;He C.;Huang X.
Peritoneal dissemination is the most common condition of metastasis in gastric cancer. The survival duration of a patient with advanced stage gastric cancer, may be improved by gene therapy. In this study, we used an oncolytic adenovirus vector (Ad/TRAIL-E1) that expresses both the TRAIL and E1A genes under the control of a tumor-specific promoter. We evaluated the anti-tumor effect of Ad/TRAIL-E1 on gastric cancer cells in vitro, as well as in vivo in a xenograft peritoneal carcinomatosis mouse model. Our data showed that Ad/TRAIL-E1 induced TRAIL-mediated apoptosis in gastric cancer cell lines, but not in the normal cell lines. In addition, Ad/TRAIL-E1 significantly inhibited peritoneal metastasis and prolonged the survival of mice without treatment-related toxicity. Therefore, tumor-specific TRAIL expression from an oncolytic adenovirus vector may provide a novel therapeutic approach for the treatment of advance stage gastric cancer with peritoneal dissemination.
登录
查看更多内容
DOI:
10.1891/9780826121646.0002
发表时间:
2018-09
期刊:
Cancer Rehabilitation
影响因子:
--
作者:
K. Miller;R. Siegel;R. Khan;A. Jemal
通讯作者:
K. Miller;R. Siegel;R. Khan;A. Jemal
影响因子:
8.8
作者:
Natatsuka R;Takahashi T;Serada S;Fujimoto M;Ookawara T;Nishida T;Hara H;Nishigaki T;Harada E;Murakami T;Miyazaki Y;Makino T;Kurokawa Y;Yamasaki M;Miyata H;Nakajima K;Takiguchi S;Kishimoto T;Mori M;Doki Y;Naka T
通讯作者:
Naka T
影响因子:
8
作者:
Lin, TY;Huang, XF;Fang, BL
通讯作者:
Fang, BL
影响因子:
6.4
作者:
Davis, J. J.;Wang, L.;Fang, B.
通讯作者:
Fang, B.
影响因子:
15.9
作者:
Kurihara, T;Brough, DE;Kufe, DW
通讯作者:
Kufe, DW